114 results
Page 2 of 6
8-K
EX-99.1
bhtk56 zw1o
11 May 22
Cocrystal Pharma Reports First Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs and Milestones
8:30am
8-K
EX-99.1
e12qmqb
23 Mar 22
Cocrystal Pharma Reports 2021 Financial Results and Provides Updates on Development Programs and Milestones
4:05pm
8-K
EX-99.1
vgx 0i90pu82t8
22 Dec 21
Regulation FD Disclosure
8:30am
8-K
EX-99.1
q1tvo9 blme8
15 Nov 21
Cocrystal Pharma Reports Third Quarter Financial Results and Provides an Update on Development
8:00am
8-K
EX-1.1
6eq5plbqn2ly r2l
5 May 21
Entry into a Material Definitive Agreement
5:02pm
8-K
EX-1.1
a0e60djxy1v kxztl5
27 Aug 20
Entry into a Material Definitive Agreement
5:25pm
424B5
lu91rbsy 82b80rd1v
27 Aug 20
Prospectus supplement for primary offering
5:24pm
424B5
pa0o9l gvx21u2w
26 Aug 20
Prospectus supplement for primary offering
5:30pm
8-K
EX-1.1
xckm lxbd
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
424B5
pv0p68rq0i5nr
1 Jul 20
Prospectus supplement for primary offering
4:49pm